Product Information

CALCIUM ACETATE 667 MG CAPSULE is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1669 per EA under NDC 23155053102. Its NADAC has been published 564 times since Nov 4, 2015.

FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the calcium acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CALCIUM ACETATE 667 MG CAPSULE

calcium acetate
$0.1669per EA
High Outlier

Strength

667 mg/1

NDC

23155053102

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CALCIUM ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202315

FDA Approved

6/29/2015

TE Code

AB

On Market Since

7/7/2015

Pharmacological Classes

Blood Coagulation Factor
Calcium
Cations
Divalent
Increased Coagulation Factor Activity
Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for CALCIUM ACETATE 667 MG CAPSULE has been published 564 times since Nov 4, 2015, and over the history we have for it it has declined 55.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1669 per EA
All-time high$0.5239 (Jul 15, 2020)
All-time low$0.1369 (Nov 20, 2024)
52-week high$0.2245
52-week low$0.1669
Median price$0.2231
Average price$0.2587
Largest weekly change+38.0% (May 13, 2020)
Weeks tracked564
Tracking sinceNov 4, 2015

Price History

1W

-0.0%

1M

-0.0%

3M

-3.6%

6M

-6.1%

1Y

-25.6%

3Y

-19.7%

5Y

-54.4%

All

-55.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the calcium acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CALCIUM ACETATE 667 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG CAPSULE, manufactured by Heritage Pharmaceuticals Inc., is $0.1669 per EA (NDC 23155053102), effective Aug 19, 2026.

How has the price of CALCIUM ACETATE 667 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has declined 55.3%. It has been tracked across 564 weekly CMS publications since Nov 4, 2015.

What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG CAPSULE?

Since Nov 4, 2015, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.5239 (Jul 15, 2020), with a median of $0.2231 per EA.

Are there cheaper alternatives to CALCIUM ACETATE 667 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of CALCIUM ACETATE 667 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CALCIUM ACETATE 667 MG CAPSULE?

CALCIUM ACETATE 667 MG CAPSULE (NDC 23155053102) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.